| Record ID | marc_uic/UIC_2022.mrc:77814365:1233 |
| Source | marc_uic |
| Download Link | /show-records/marc_uic/UIC_2022.mrc:77814365:1233?format=raw |
LEADER: 01233mas a2200373 a 4500
001 9970439012005897
005 20200413103706.0
008 881215c198u9999nyufr p s||| 0 |a0eng d
010 $asn 88035230
035 $a9817129-01carli_network
035 $a(OCoLC)ocm18902931
035 $9ACY5784UI
035 $a(UICdb)704390
035 $a(EXLNZ-01CARLI_NETWORK)991097725099705816
040 $aFUG$cFUG$dHUL$dNST$dIUL$dNST$dUICdb
042 $alcd
043 $an-us---
050 14 $aHF5415.3$b.M43
245 00 $aMediamark Research remedies report.
246 10 $aRemedies report
260 00 $a[New York, N.Y.] :$bMediamark Research Inc.,
300 $av. ;$c28 cm.
310 $aSemiannual
500 $a"P-9."
500 $aDescription based on: Spring 1988.
650 0 $aDrugs, Nonprescription$zUnited States$xMarketing$xStatistics$xPeriodicals.
650 0 $aPatent medicines$zUnited States$xMarketing$xStatistics$xPeriodicals.
650 0 $aMarket surveys$zUnited States$xStatistics$xPeriodicals.
710 20 $aMediamark Research Inc.
780 00 $tRemedies$x0894-7244$w(DLC)sn 85019028$w(OCoLC)11633852
936 $aSpring 1989 LIC
948 $aMK
959 $a(UICdb)704390
959 $a(UICdb)704390$9LOCAL